Literature DB >> 1550782

Effect of transferrin, lactoferrin and chelated iron on human T-lymphocytes.

A Djeha1, J H Brock.   

Abstract

The effect of different forms of iron and iron-binding proteins on the proliferative response of human lymphocytes to phytohaemagglutinin (PHA) has been studied. Transferrin enhanced proliferation, the effect being proportional to the degree of iron saturation up to 100%, but decreased if additional iron was present. The lipophilic complex ferric pyridoxal isonicotinoyl hydrazone (FePIH) also enhanced proliferation, but the hydrophilic complex ferric nitrilotriacetate (FeNTA) was inhibitory. Fe-lactoferrin could not substitute for Fe-transferrin, although iron-free (apo) lactoferrin abrogated the inhibitory effect seen when iron levels exceed the binding capacity of transferrin. Lymphocyte ferritin levels increased 4-fold as the iron saturation of transferrin increased from 0 to 90% but no further increase was seen at higher iron levels, suggesting that lymphocytes are poorly equipped to detoxify excess iron through stimulation of ferritin synthesis. The effect of iron on the CD4:CD8 ratio after 72 h culture with PHA was also examined. The ratio was approximately 2:1 for cells cultured with transferrin at iron saturations between 0 and 75%, with FePIH, or without either, but decreased to 1.1:1 when cells were cultured in the presence of FeNTA, regardless of whether or not saturated Fe-transferrin was present. These results show that iron can affect lymphocyte proliferation and subset ratios in different ways according to the form and amount present, and may help to explain some of the immunological disturbances associated with iron overload.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1550782     DOI: 10.1111/j.1365-2141.1992.tb08906.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells.

Authors:  D Legrand; P H van Berkel; V Salmon; H A van Veen; M C Slomianny; J H Nuijens; G Spik
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

Review 2.  Interaction of inflammatory cytokines and erythropoeitin in iron metabolism and erythropoiesis in anaemia of chronic disease.

Authors:  M Jongen-Lavrencic; H R Peeters; G Vreugdenhil; A J Swaak
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

Review 3.  The role of iron and iron binding proteins in lymphocyte physiology and pathology.

Authors:  J D Kemp
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

Review 4.  Association of iron with colorectal cancer.

Authors:  E D Weinberg
Journal:  Biometals       Date:  1994-07       Impact factor: 2.949

5.  Molecular identification and expression of differentially regulated genes of the European flounder, Platichthys flesus, submitted to pesticide exposure.

Authors:  J Marchand; A Tanguy; G Charrier; L Quiniou; E Plee-Gauthier; J Laroche
Journal:  Mar Biotechnol (NY)       Date:  2006-03-17       Impact factor: 3.619

6.  Physiological implications of NTBI uptake by T lymphocytes.

Authors:  Jorge P Pinto; João Arezes; Vera Dias; Susana Oliveira; Inês Vieira; Mónica Costa; Matthijn Vos; Anna Carlsson; Yuri Rikers; Maria Rangel; Graça Porto
Journal:  Front Pharmacol       Date:  2014-02-26       Impact factor: 5.810

7.  Thalassemia and hepatocellular carcinoma: links and risks.

Authors:  Maria Marsella; Paolo Ricchi
Journal:  J Blood Med       Date:  2019-09-17

8.  Arctigenin inhibits prostate tumor growth in high-fat diet fed mice through dual actions on adipose tissue and tumor.

Authors:  Qiongyu Hao; Tanya Diaz; Alejandro Del Rio Verduzco; Clara E Magyar; Jin Zhong; Yahya Elshimali; Matthew B Rettig; Susanne M Henning; Jaydutt V Vadgama; Piwen Wang
Journal:  Sci Rep       Date:  2020-01-29       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.